Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2014

01-05-2014 | Healthcare Policy and Outcomes

In Memoriam: Donald L. Morton, MD (1934–2014): An Icon in Surgical Oncology

Past President, Society of Surgical Oncology (1992–1993) and Associate Editor, Annals of Surgical Oncology (1993–2014)

Authors: Charles M. Balch, MD, FACS, Mark S. Roh, MD, V. Suzanne Klimberg, MD, Deborah A. Whippen, BA

Published in: Annals of Surgical Oncology | Issue 5/2014

Login to get access

Excerpt

Donald L. Morton, M.D. (Fig. 1), who passed away on 10 January 2014, was a true legend in the field of surgical oncology, as well as a pioneer in the field of immunotherapy. As President-elect and then President of the Society of Surgical Oncology from 1992 to 1993, he was instrumental in the launching the Annals of Surgical Oncology. Dr. Morton was an associate editor of the journal for 20 years, during which time he was a major contributor of many high impact articles. He was also a cancer survivor, and publically described his experience with two separate melanomas and a lengthy battle with lymphoma.
Literature
1.
go back to reference Wood WC. Honoring Donald M. Morton, MD: Society of Surgical Oncology President, 1992–1993. Ann Surg Oncol. 2003;10:1125–7.PubMedCrossRef Wood WC. Honoring Donald M. Morton, MD: Society of Surgical Oncology President, 1992–1993. Ann Surg Oncol. 2003;10:1125–7.PubMedCrossRef
2.
go back to reference Balch CM. Donald L. Morton, MD … a living legend in surgical oncology. J Surg Oncol. 2011;104:338–40. PubMed Balch CM. Donald L. Morton, MD … a living legend in surgical oncology. J Surg Oncol. 2011;104:338–40. PubMed
3.
go back to reference Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.PubMedCrossRef Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.PubMedCrossRef
5.
go back to reference Silverstein MJ, deKernion JD, Morton DL. Malignant-melanoma metastatic to bladder - regression following intratumor injection of BCG vaccine. JAMA. 1974;229:688. Silverstein MJ, deKernion JD, Morton DL. Malignant-melanoma metastatic to bladder - regression following intratumor injection of BCG vaccine. JAMA. 1974;229:688.
6.
go back to reference Morton DL, Eilber FR, Townsend CM, et al. Limb salvage from a multidisciplinary treatment approach for skeletal and soft-tissue sarcomas of extremity. Ann Surg. 1976;184:268–78.PubMedCentralPubMedCrossRef Morton DL, Eilber FR, Townsend CM, et al. Limb salvage from a multidisciplinary treatment approach for skeletal and soft-tissue sarcomas of extremity. Ann Surg. 1976;184:268–78.PubMedCentralPubMedCrossRef
7.
go back to reference Wood WC. Honoring Donald L. Morton, MD: Society of Surgical Oncology President. Ann Surg Oncol. 2003;10:1125–7.PubMedCrossRef Wood WC. Honoring Donald L. Morton, MD: Society of Surgical Oncology President. Ann Surg Oncol. 2003;10:1125–7.PubMedCrossRef
8.
go back to reference Fee HJ, Robinson DS, Sample WF, Graham LS, Holmes EC, Morton DL. The Determination of lymph shed by colloidal gold scanning patients with malignant melanoma: a preliminary study. Surgery. 1978;84:626–2. Fee HJ, Robinson DS, Sample WF, Graham LS, Holmes EC, Morton DL. The Determination of lymph shed by colloidal gold scanning patients with malignant melanoma: a preliminary study. Surgery. 1978;84:626–2.
10.
go back to reference Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302–11.PubMedCentralPubMed Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302–11.PubMedCentralPubMed
11.
go back to reference Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–17.PubMedCrossRef Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–17.PubMedCrossRef
12.
go back to reference Morton DL. Sentinel node mapping and an international sentinel node society: current issues and future directions. Ann Surg Oncol. 2004;11:137S–43S.PubMed Morton DL. Sentinel node mapping and an international sentinel node society: current issues and future directions. Ann Surg Oncol. 2004;11:137S–43S.PubMed
13.
go back to reference Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609.PubMedCrossRef Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609.PubMedCrossRef
14.
go back to reference Balch CM and Gershenwald JE. Clinical value of the sentinel-node biopsy in primary cutaneous melanoma. N Engl J Med. 2014;370:663–4.PubMedCrossRef Balch CM and Gershenwald JE. Clinical value of the sentinel-node biopsy in primary cutaneous melanoma. N Engl J Med. 2014;370:663–4.PubMedCrossRef
Metadata
Title
In Memoriam: Donald L. Morton, MD (1934–2014): An Icon in Surgical Oncology
Past President, Society of Surgical Oncology (1992–1993) and Associate Editor, Annals of Surgical Oncology (1993–2014)
Authors
Charles M. Balch, MD, FACS
Mark S. Roh, MD
V. Suzanne Klimberg, MD
Deborah A. Whippen, BA
Publication date
01-05-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 5/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3619-4

Other articles of this Issue 5/2014

Annals of Surgical Oncology 5/2014 Go to the issue